By [Your Name/Editorial Staff]
June 01, 2026
For decades, the public narrative surrounding BRCA gene mutations has been inextricably linked to women’s health. Often dubbed the "breast cancer gene," the BRCA1 and BRCA2 mutations have become synonymous with screenings for breast and ovarian cancer. However, this narrow focus obscures a biological reality that affects half the population: men carry these mutations, men develop associated cancers, and men are often the primary vehicles through which these genetic risks are transmitted across generations.
Doug Bank, a long-time cancer advocate and member of the Sharsheret Men’s Leadership Council, knows this reality intimately. His journey—from a testicular cancer survivor at 26 to a BRCA2 carrier diagnosed with prostate cancer at 56—serves as a powerful case study for why the conversation around hereditary cancer must be gender-inclusive.
The Chronology of a Genetic Legacy
Doug Bank’s path to understanding his own genetic risk was neither linear nor immediate. His initial brush with cancer in his twenties was not linked to a hereditary mutation, but it sparked a lifelong commitment to advocacy.
- The Early Years (1990s): Following a Stage I testicular cancer diagnosis at 26, Bank found himself navigating an over-medicalized system. The lack of clear information and the pressure toward aggressive, potentially unnecessary treatment motivated him to create his own support networks, eventually leading to a nonprofit dedicated to adolescent and young adult (AYA) cancer care.
- The Intersection (Mid-2000s): During his work with the LIVESTRONG Young Adult Alliance, Bank met Rochelle Shoretz, the visionary founder of Sharsheret, an organization dedicated to supporting Jewish women and families facing breast and ovarian cancer. At the time, the connection seemed purely professional.
- The Turning Point (2009): When his wife’s physician prompted a deep dive into his own family history, the patterns became impossible to ignore. A "pedigree"—the medical term for a detailed family tree—revealed a haunting prevalence of cancer: his father’s prostate cancer, his aunt’s breast cancer, his mother’s sibling’s cancers, and a string of breast cancer diagnoses among his father’s female cousins. Genetic testing confirmed the presence of a BRCA2 mutation.
- The Ripple Effect (2010s–2020s): The knowledge proved to be a double-edged sword. It provided life-saving context for his brother’s late-stage pancreatic cancer diagnosis and empowered his children to take control of their own health. When his daughter discovered a lump at age 24, her known BRCA2 status ensured she was treated as a high-risk patient, leading to rapid, life-saving intervention. Finally, in his mid-fifties, Bank himself faced a BRCA-related prostate cancer diagnosis.
Supporting Data: The Biological Reality for Men
The medical community is increasingly acknowledging that the "women’s cancer" label is a misnomer. BRCA1 and BRCA2 are tumor suppressor genes. When they mutate, the body’s ability to repair damaged DNA is compromised, leading to an increased risk of malignancy.
The Risks for Men
- Prostate Cancer: Men with a BRCA2 mutation are at a significantly higher risk for developing prostate cancer, which often presents at a younger age and can be more aggressive than in the general population.
- Male Breast Cancer: While rare, men can and do develop breast cancer. The risk is substantially higher for those with BRCA mutations, particularly BRCA2.
- Pancreatic and Melanoma: There is a documented association between BRCA mutations and an increased risk of pancreatic cancer and certain skin cancers.
The Inheritance Factor
BRCA mutations are autosomal dominant, meaning a child of a carrier has a 50% chance of inheriting the mutation, regardless of their sex. A man who carries the mutation can pass it to his sons just as easily as his daughters. This makes the "father’s side" of the family tree just as vital to the puzzle as the maternal side.
Clinical Implications: Why "Not Knowing" is a Risk
A common sentiment among men—and even some physicians—is that genetic testing for men is unnecessary unless they are showing symptoms. This "ignorance is bliss" approach is being heavily challenged by current clinical outcomes.
The Anxiety Paradox
Many doctors historically discouraged testing younger relatives, fearing it would cause unnecessary anxiety. However, as Bank points out, the anxiety of the unknown is often more corrosive than the certainty of a diagnosis. Knowing one’s status allows for early screening protocols, such as more frequent prostate-specific antigen (PSA) testing or breast self-exams for men, which can move the needle from late-stage treatment to early intervention.
The Role of Genetic Counseling
Genetic testing is not a "do-it-yourself" project. Experts emphasize that the process should be guided by a certified genetic counselor. A counselor helps the patient interpret the findings, understand the implications for extended family members, and navigate the psychological impact of the results. As Bank notes, not every cancer in a family tree is linked to a known mutation; sometimes, it is a complex interplay of unidentified factors. Genetic testing is a tool for precision, not a crystal ball.
Sharsheret and the Evolution of Support
Sharsheret, once focused primarily on women, has expanded its mission to recognize that cancer is a "family affair." By integrating the Men’s Leadership Council, the organization acknowledges that men play multiple roles in the cancer landscape: they are patients, they are caregivers, and they are carriers.
When a family is hit by a BRCA-related diagnosis, the systemic stress is immense. Organizations like Sharsheret provide the bridge between the clinical reality (the mutation) and the human reality (the fear, the logistics, and the support).
Official Responses and Future Directions
Public health experts are shifting their stance on universal screening. While universal testing is not yet the standard for the general male population, there is a growing consensus that men with a family history of breast, ovarian, pancreatic, or prostate cancer should advocate for their own genetic assessment.
"Men should not stand outside these conversations," says Bank. "We are the missing link in the hereditary cancer narrative."
Key Takeaways for Men:
- Map Your Tree: Document cancers on both your mother’s and father’s sides of the family.
- Be Your Own Advocate: If your family history suggests a high risk, push for a referral to a genetic counselor.
- Break the Stigma: Cancer has no gender. Engaging in the conversation about BRCA is a protective act for your children and future generations.
- Support Systems Matter: Utilize organizations that offer holistic support. Dealing with a diagnosis is physically demanding; dealing with the implications of genetics is emotionally complex.
Conclusion
The story of the BRCA mutation is evolving. It is no longer just a chapter in a textbook about women’s health; it is a vital part of the broader conversation about hereditary disease and precision medicine. As more men like Doug Bank step forward to share their experiences, the stigma surrounding hereditary cancer continues to dissolve.
The lesson is clear: Knowledge is not just power; it is an active strategy for survival. By embracing the conversation, men are not only taking charge of their own health but are also becoming the guardians of their families’ futures. When cancer enters the room, the most effective weapon remains an informed, transparent, and proactive approach to genetic health.
About the Author
